Vendor, Rancho Mirage, CA
Cell Surgical Network Corporation
UEI LQ77JMMJUMK5, CAGE 8CF77
1 award and -$337,500 obligated between January 29, 2026 and January 29, 2026, 100% under full and open competition, against 228.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | -$337,500 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| FA864922P0005Purchase Order, January 29, 2026, Full and Open Competition After Exclusion of Sources, 228 offers | FA8649 USAF SBIR STTR Cntrctng AFRLDepartment of the Air Force | Efficacy and Safety of Fresh Stromal Vascular Fraction for Combat Veterans with PTSD and Blast Trauma ExposureNAICS 541715, PSC AC32 | -$337,500 |
- Places of performance
- California
- Product and service codes
- AC32 National Defense R&D Services; Defense-Related Activities; Applied Research
- Transactions
- 1 across 1 awards